Onsite Covid-19 Testing
CAP/CLIA ACCREDITED LABORATORIES, HIGHLY SPECIFIC TESTS, AND LICENSED HEALTHCARE PARTNERS.
Best-in-Class Rapid Antigen Testing
SAFERPLUS™ offers Rapid Antigen testing that can be performed on-site at schools, work places, or businesses by our licensed health care partners.
We offer the highest specificity and sensitivity tests on the market at competitive prices. Our comfortable testing options include a short nasal swab test that is simple to use and non-invasive. Our solution includes sample collection, analysis, and interpretation of health data in minutes!
Currently offering the Lucira, CovClear, and CareStart tests!
98.5% Sensitivity and 100% Specificity!
Rapid Results in 3-20 Minutes
Made in the USA
Highly Sensitive and Specific
Self-Contained, Safe Disposal
Your Partner for Group Surveillance Testing.
Regular testing helps stop the spread of Covid-19 before a shutdown is necessary.
The CDC reports that "Over 85% of patients who contract COVID-19 do not have symptoms. Asymptomatic patients can still transmit COVID-19 to others, which is why testing is so important."
An outbreak could be starting at your school or place of work and you may not know without testing.
We bring our tailored solutions to you so that you can focus on getting back to what you do best.
The risk of outbreak increases from 5% to 90% without an evidence-based program.
- The Lancet
rapid turnaround pCR testing
We're proud to offer the fastest turnaround time in the industry for lab-based PCR testing! Get results in as little as 1-hour with our express service. Guaranteed 24-hour turnaround time.
Pooled/Group PCR Testing
Save Time, Money and Resources with Pooled Testing Solutions from SAFERPLUS™.
Lessen Covid-19 exposure and transmission rates in your organization. Save up to 75% compared to individual testing!
We can support significant daily testing volume. Give us a call to get a free assessment for your needs.
Fast Turnaround Time
Not for individual testing. No medical test is 100% accurate, and tests for COVID-19 are no exception. Results from antigen testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to determine infection status.